Strata Skin Sciences EBITDA Margin 2010-2023 | SSKN
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Strata Skin Sciences (SSKN) over the last 10 years. The current EBITDA margin for Strata Skin Sciences as of December 31, 2023 is .
| Strata Skin Sciences EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-12-31 | $0.03B | $-0.00B | -5.88% |
| 2023-09-30 | $0.04B | $0.00B | 5.56% |
| 2023-06-30 | $0.04B | $0.00B | 5.56% |
| 2023-03-31 | $0.04B | $0.00B | 5.41% |
| 2022-12-31 | $0.04B | $0.00B | 5.56% |
| 2022-09-30 | $0.03B | $0.00B | 2.94% |
| 2022-06-30 | $0.03B | $0.00B | 3.03% |
| 2022-03-31 | $0.03B | $0.00B | 3.23% |
| 2021-12-31 | $0.03B | $0.00B | 3.33% |
| 2021-09-30 | $0.03B | $0.00B | 3.57% |
| 2021-06-30 | $0.03B | 0 | 0.00% |
| 2021-03-31 | $0.02B | $-0.00B | -4.35% |
| 2020-12-31 | $0.02B | 0 | 0.00% |
| 2020-09-30 | $0.03B | 0 | 0.00% |
| 2020-06-30 | $0.03B | 0 | 0.00% |
| 2020-03-31 | $0.03B | $0.00B | 3.23% |
| 2019-12-31 | $0.03B | $0.00B | 3.23% |
| 2019-09-30 | $0.03B | $0.00B | 3.33% |
| 2019-06-30 | $0.03B | $0.00B | 6.45% |
| 2019-03-31 | $0.03B | $0.00B | 6.67% |
| 2018-12-31 | $0.03B | $0.00B | 6.67% |
| 2018-09-30 | $0.03B | 0 | 0.00% |
| 2018-06-30 | $0.03B | $0.00B | 3.33% |
| 2018-03-31 | $0.03B | $0.00B | 12.90% |
| 2017-12-31 | $0.03B | $0.01B | 19.35% |
| 2017-09-30 | $0.03B | $0.01B | 33.33% |
| 2017-06-30 | $0.03B | $0.01B | 32.26% |
| 2017-03-31 | $0.03B | $0.01B | 25.81% |
| 2016-12-31 | $0.03B | $0.01B | 18.75% |
| 2016-09-30 | $0.03B | $0.00B | 12.12% |
| 2016-06-30 | $0.03B | $0.01B | 18.18% |
| 2016-03-31 | $0.03B | $-0.00B | -11.54% |
| 2015-12-31 | $0.02B | $-0.00B | -22.22% |
| 2015-09-30 | $0.01B | $-0.01B | -77.78% |
| 2015-06-30 | $0.00B | $-0.01B | -1400.00% |
| 2015-03-31 | $0.00B | $-0.01B | inf% |
| 2014-12-31 | $0.00B | $-0.01B | inf% |
| 2014-09-30 | $0.00B | $-0.02B | inf% |
| 2014-06-30 | $0.00B | $-0.02B | inf% |
| 2014-03-31 | $0.00B | $-0.02B | inf% |
| 2013-12-31 | $0.00B | $-0.02B | inf% |
| 2013-09-30 | $0.00B | $-0.02B | inf% |
| 2013-06-30 | $0.00B | $-0.02B | inf% |
| 2013-03-31 | $0.00B | $-0.02B | inf% |
| 2012-12-31 | $0.00B | $-0.02B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.019B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.221B | 21.82 |
| Inspire Medical Systems (INSP) | United States | $6.999B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.463B | 0.00 |
| Axonics (AXNX) | United States | $3.394B | 0.00 |
| 10x Genomics (TXG) | United States | $3.206B | 0.00 |
| Enovis (ENOV) | United States | $3.022B | 22.96 |
| Azenta (AZTA) | United States | $2.872B | 234.09 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.869B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.629B | 0.00 |
| Privia Health (PRVA) | United States | $2.135B | 94.68 |
| Schrodinger (SDGR) | United States | $1.688B | 0.00 |
| Omnicell (OMCL) | United States | $1.246B | 30.48 |
| Phreesia (PHR) | United States | $1.154B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.793B | 0.00 |
| Standard BioTools (LAB) | United States | $0.685B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Talkspace (TALK) | United States | $0.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.332B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.328B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| American Well (AMWL) | United States | $0.156B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.152B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.136B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
| Outset Medical (OM) | United States | $0.123B | 0.00 |
| TruBridge (TBRG) | United States | $0.115B | 4.91 |
| 111 (YI) | China | $0.084B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.077B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |